Home Combat Arthritis Regeneron's Arthritis Drug Fails COVID-19 Trial

Regeneron's Arthritis Drug Fails COVID-19 Trial

Jul 06, 2020 comments off

Regeneron’s Arthritis Drug Fails COVID-19 Trial

Kevzara failed to help the most severely affected COVID-19 patients.

Read More…

You May Also Like

Initial data from a pair of clinical trials may revive interest in arthritis drugs as COVID-19 treatments

Roche says its drugs reduce ventilator need for COVID-19 patients – Reuters UK

Flu outbreaks may be linked to COVID-19; arthritis drug benefit seen – Reuters India

Flu outbreaks may be linked to COVID-19; arthritis drug benefit seen – Reuters UK

Eli Lilly's drug cuts COVID-19 recovery time in remdesivir-combo study – Reuters India

Eli Lilly's rheumatoid arthritis drug helps recovery in COVID-19 patients – Reuters